China Pharma Holdings (MUN:XQJ) - Stock Price, News & Analysis

XQJ Stock Overview

Develops, manufactures, and markets generic and branded pharmaceutical, and biochemical products to hospitals and private retailers in the People’s Republic of China. More details

XQJ fundamental analysis
Snowflake Score
Valuation	2/6
Future Growth	0/6
Past Performance	0/6
Financial Health	1/6
Dividends	0/6

Risk Analysis

Highly volatile share price over the past 3 months compared to the German market

Shareholders have been substantially diluted in the past year

Does not have a meaningful market cap (€4M)

Has less than 1 year of cash runway

China Pharma Holdings, Inc. Competitors

Biofrontera

XTRA:B8FK

€16.4m

SynBiotic

DUSE:SBX

€27.9m

Cantourage Group

XTRA:HIGH

€55.6m

Apontis Pharma

XTRA:APPH

€80.3m

Price History & Performance

Summary of all time highs, changes and price drops for China Pharma Holdings
Historical stock prices
Current Share Price	US$0.20
52 Week High	US$0.27
52 Week Low	US$0.19
Beta	0.71
11 Month Change	-6.28%
3 Month Change	n/a
1 Year Change	n/a
33 Year Change	n/a
5 Year Change	n/a
Change since IPO	-4.78%

Recent updates

Shareholder Returns

	XQJ	DE Pharmaceuticals	DE Market
7D	-4.6%	-1.2%	-0.02%
1Y	n/a	-20.1%	8.2%

Return vs Industry: Insufficient data to determine how XQJ performed against the German Pharmaceuticals industry.

Return vs Market: Insufficient data to determine how XQJ performed against the German Market.

Price Volatility

Is XQJ's price volatile compared to industry and market?
XQJ volatility
XQJ Average Weekly Movement	13.0%
Pharmaceuticals Industry Average Movement	6.9%
Market Average Movement	4.8%
10% most volatile stocks in DE Market	10.9%
10% least volatile stocks in DE Market	2.4%

Stable Share Price: XQJ's share price has been volatile over the past 3 months compared to the German market.

Volatility Over Time: Insufficient data to determine XQJ's volatility change over the past year.

About the Company

Founded	Employees	CEO	Website
n/a	231	Zhilin Li	www.chinapharmaholdings.com

China Pharma Holdings, Inc. develops, manufactures, and markets generic and branded pharmaceutical, and biochemical products to hospitals and private retailers in the People’s Republic of China. The company provides products in the form of dry powder injectables, liquid injectables, tablets, capsules, and cephalosporin oral solutions. Its products include Cerebroprotein Hydroloysate injection to treat memory decline and attention deficit; Gastrodin injection for tiredness, loss of concentration, poor sleep, and traumatic syndromes of the brain; Propylgallate injection to treat cerebral thrombosis, coronary heart disease, and after surgery complications; Ozagrel Sodium to treat acute thrombotic cerebral infarction and dyskinesia; Alginic Sodium Diester injection for ischemic heart, cerebrovascular, and high lipoprotein blood diseases; Bumetanide injection to treat edema diseases; and Candesartan for hypertension.

China Pharma Holdings, Inc. Fundamentals Summary

How do China Pharma Holdings's earnings and revenue compare to its market cap?
XQJ fundamental statistics
Market cap	€3.68m
Earnings (TTM)	-€4.56m
Revenue (TTM)	€5.32m

0.7x

P/S Ratio

-0.8x

P/E Ratio

Is XQJ overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
XQJ income statement (TTM)
Revenue	US$5.54m
Cost of Revenue	US$7.45m
Gross Profit	-US$1.90m
Other Expenses	US$2.84m
Earnings	-US$4.74m

Last Reported Earnings

Sep 30, 2024

Next Earnings Date

n/a

Earnings per share (EPS)	-0.25
Gross Margin	-34.34%
Net Profit Margin	-85.56%
Debt/Equity Ratio	60.5%

How did XQJ perform over the long term?

See historical performance and comparison

China Pharma Holdings MUN:XQJ Stock Report